Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft vs. Host Disease (GvHD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04087291
What this trial is testing

Veterans Response to Dosage in Chiropractic Therapy

Who this might be right for
Low Back PainPatient Acceptance of Health CareVeterans Health
Palmer College of Chiropractic 766
Not applicableStudy completedNCT02398708
What this trial is testing

Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT

Who this might be right for
Graft vs Host DiseaseGraft Versus Host DiseaseHematopoietic Stem Cell Transplantation+1 more
University of Florida 38
Post-approval studies (Phase 4)Looking for participantsNCT07029958
What this trial is testing

Improved Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Protocol for the Treatment of Epstein Barr Virus T/NK Lymphoproliferative Disease (EBV-T/NK LPD) and Prevention of Post Transplant Graft-versus-host Disease

Who this might be right for
EBV-T/NK LPD
Beijing Children's Hospital 48
Early research (Phase 1)Study completedNCT01181024
What this trial is testing

A Study on Safety, Tolerability and Pharmacokinetics of RO5303253 in Healthy Volunteers and Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic, Healthy Volunteer
Hoffmann-La Roche 82
Testing effectiveness (Phase 2)Study completedNCT01323920
What this trial is testing

Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndrome
Dana-Farber Cancer Institute 35
Early research (Phase 1)Study completedNCT00495755
What this trial is testing

Campath in Chronic GVHD

Who this might be right for
Chronic Graft-vs.-Host Disease
Dana-Farber Cancer Institute 13
Early research (Phase 1)Study completedNCT05873907
What this trial is testing

Evaluate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AMG 592 in Healthy Participants

Who this might be right for
Chronic Graft-versus-host Disease (cGVHD)
Amgen 64
Not applicableStudy completedNCT02754934
What this trial is testing

Development of a Self-administered Neck Mobility Assessment Tool in Chronic Neck Pain Patients.

Who this might be right for
Neck Pain
Balgrist University Hospital 50
Large-scale testing (Phase 3)Ended earlyNCT03805789
What this trial is testing

The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant

Who this might be right for
Acute-graft-versus-host Disease
CSL Behring 222
Not applicableUnknownNCT03251352
What this trial is testing

TKI Discontinuation in CML Patients of China

Who this might be right for
LeukemiaMyelogenousChronic+2 more
Shenzhen Second People's Hospital 98
Early research (Phase 1)Study completedNCT00079625
What this trial is testing

Stem Cell Transplant With Th2/Tc2 Cells to Treat Advanced Breast Cancer

Who this might be right for
Breast Neoplasms
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Looking for participantsNCT04380740
What this trial is testing

Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis

Who this might be right for
Graft Vs Host Disease
Boston Children's Hospital 160
Testing effectiveness (Phase 2)Ended earlyNCT04269850
What this trial is testing

Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD

Who this might be right for
Intestinal GVHD
St. Petersburg State Pavlov Medical University 2
Testing effectiveness (Phase 2)Looking for participantsNCT05436418
What this trial is testing

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

Who this might be right for
Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell Transplantation
National Cancer Institute (NCI) 260
Not applicableLooking for participantsNCT07079150
What this trial is testing

Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

Who this might be right for
Hepatitis B, Chronic (CHB)Hepatitis BHepatitis B Virus (HBV)
First Affiliated Hospital Xi'an Jiaotong University 1,500
Large-scale testing (Phase 3)Study completedNCT01241591
What this trial is testing

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 1,101
Not applicableStudy completedNCT01036958
What this trial is testing

Development and Validation of a Symptom Scale for Children With Chronic Graft-versus-Host Disease

Who this might be right for
Chronic Graft-Versus-Host-Disease
National Cancer Institute (NCI) 3
Not applicableStudy completedNCT03916055
What this trial is testing

Internet-delivered Behaviour Therapy for Children and Adolescents With Tourette's Disorder

Who this might be right for
Tourette's DisorderPersistent (Chronic) Motor or Vocal Tic Disorder
Karolinska Institutet 221
Testing effectiveness (Phase 2)Active Not RecruitingNCT03983850
What this trial is testing

Optimizing PTCy Dose and Timing

Who this might be right for
Graft Versus Host DiseaseHematologic Neoplasms
National Cancer Institute (NCI) 105
Not applicableEnded earlyNCT00735735
What this trial is testing

Measurement of Substance P in Saliva of Low Back Pain Patients

Who this might be right for
Low Back Pain
Kovacs Foundation 40
Next Page